Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

AC Immune (ACIU) Debt Ratio (2017 - 2020)

AC Immune (ACIU) reported Debt Ratio of 0.0 for Q3 2020, down 39.63% year-over-year from 0.0 in Q4 2019, and up 2.84% on a QoQ basis from 0.0 in Q2 2020.

AC Immune (ACIU) has 4 years of Debt Ratio data on file, last reported at 0.0 in Q3 2020.

  • Quarterly Debt Ratio fell 39.63% year-over-year to 0.0 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was 0.0 (down 39.63% YoY) and the FY2019 annual result came in at 0.0, down 16.7% from the prior year.
  • Debt Ratio advanced to 0.0 in Q3 2020 per ACIU's latest filing, from 0.0 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.0 in Q4 2017 and bottomed at 0.0 in Q2 2019.
  • The 4-year median for Debt Ratio is 0.0 (2019), against an average of 0.0.
  • Peak annual rise in Debt Ratio reached 59482999.56% in 2020, while the deepest fall reached 39.63% in 2020.
  • Tracing ACIU's Debt Ratio over 4 years: stood at 0.0 in 2017, then retreated by 29.41% to 0.0 in 2018, then dropped by 16.7% to 0.0 in 2019, then plunged by 44.97% to 0.0 in 2020.
  • Per Business Quant, the three latest ACIU Debt Ratio figures stand at 0.0 (Q3 2020), 0.0 (Q2 2020), and 0.0 (Q1 2020).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.18
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 1.41
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.05
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 AC Immune 325.88 Mn 211.53 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2020 0.00
Jun 30, 2020 0.00
Mar 31, 2020 0.00
Dec 31, 2019 0.00
Sep 30, 2019 0.00
Jun 30, 2019 0.00
Mar 31, 2019 0.00
Dec 31, 2018 0.00
Dec 31, 2017 0.00